Journal article · 2024 · Open access

Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective

Burcu Binici, Zahra Rattray, Assaf Zinger, Yvonne Perrie

Journal of Controlled Release, 377, 162–173 · Published 18 November 2024 · DOI 10.1016/j.jconrel.2024.11.010

Open full textCite this paper

In brief

“Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective” is a 2024 journal article by Burcu Binici and 3 co-authors, published in Journal of Controlled Release. OpenAlex counts 79 citations as of 21 November 2026, which puts it in the top 1% of works published in 2024 by citations. It is open access under a CC BY licence: the full text is free to read at Journal of Controlled Release.

Citations
79
Most cited in
2026 (45)
Field-weighted impact
7.66
References
39
Authors
4

Abstract

Ionizable lipids are widely recognized as the crucial component of lipid nanoparticles (LNPs). They enable mRNA encapsulation, shield it from enzymatic degradation, facilitate cellular uptake, and foster its cytosolic release for subsequent translation into proteins. In addition, PEGylated lipids are added to stabilize the particles in storage and in vivo. In this study, we investigate the potency of LNPs prepared using commonly adopted ionizable and pegylated lipids in vitro (using HEK293 cells) and in vivo (mouse studies) to consider the impact of structure on potency. LNPs were prepared using a fixed molar ratio of DSPC: Cholesterol: ionizable/cationic lipid: PEG lipid (10:38.5:50:1.5 mol%). All LNP formulations exhibited similar critical quality attributes (CQAs), including particle size <100 nm, low PDI (<0.2), near-neutral zeta potential, and high encapsulation efficiency (>90%). However, the potency of these LNPs, as measured by in vitro mRNA expression and in vivo expression following intramuscular injection in mice varied significantly. LNPs formulated with SM-102 exhibited the highest expression in vitro, whilst in vivo SM-102 and ALC-0315 LNPs showed significantly higher mRNA expression than DLin-MC3-DMA (MC3), DODAP and DOTAP LNPs. We also investigated the effect of PEG lipid choice (ALC-0159, DMG-PEG2k, and DSPE-PEG2k), which did not impact LNP CQAs, nor their clearance from the injection site. However, PEG lipid choice significantly influenced mRNA expression with the incorporation of DSPE-PEG2k reducing expression. This work contributes valuable insights to the evolving landscape of mRNA research, emphasizing that CQAs are a marker of the quality of the LNP production process, but not discriminatory regarding LNP potency. Similarly, standard in vitro studies do not provide insights into in vivo potency. These results further emphasize the intricacies of formulation design and the importance of bridging gaps between experimental outcomes in different settings.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Binici, B., Rattray, Z., Zinger, A., & Perrie, Y. (2024). Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective. Journal of Controlled Release, 377, 162–173. https://doi.org/10.1016/j.jconrel.2024.11.010

MLA 9

Binici, Burcu, et al. “Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective.” Journal of Controlled Release, vol. 377, 2024, pp. 162–173. https://doi.org/10.1016/j.jconrel.2024.11.010.

Chicago

Binici, Burcu, Zahra Rattray, Assaf Zinger, and Yvonne Perrie. 2024. “Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective.” Journal of Controlled Release 377: 162–173. https://doi.org/10.1016/j.jconrel.2024.11.010.

Harvard

Binici, B. et al. (2024) ‘Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective’, Journal of Controlled Release, 377, pp. 162–173. doi:10.1016/j.jconrel.2024.11.010.

IEEE

B. Binici, Z. Rattray, A. Zinger, and Y. Perrie, “Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective,” Journal of Controlled Release, vol. 377, pp. 162–173, 2024, doi: 10.1016/j.jconrel.2024.11.010.

BibTeX

@article{binici2024exploring,
  title     = {{Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective}},
  author    = {Binici, Burcu and Rattray, Zahra and Zinger, Assaf and Perrie, Yvonne},
  journal   = {Journal of Controlled Release},
  year      = {2024},
  volume    = {377},
  pages     = {162--173},
  doi       = {10.1016/j.jconrel.2024.11.010},
  url       = {https://doi.org/10.1016/j.jconrel.2024.11.010}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery

  • lipid nanoparticles
  • mRNA delivery
  • ionizable lipids
  • PEGylated lipids
  • SM-102
  • ALC-0315
  • DOTAP
  • critical quality attributes

Work with this paper

Most-cited papers in Biochemistry, Genetics and Molecular Biology

All highly cited Biochemistry, Genetics and Molecular Biology papers

Questions about this paper

How do I cite this paper in APA style?

Binici, B., Rattray, Z., Zinger, A., & Perrie, Y. (2024). Exploring the impact of commonly used ionizable and pegylated lipids on mRNA-LNPs: A combined in vitro and preclinical perspective. Journal of Controlled Release, 377, 162–173. https://doi.org/10.1016/j.jconrel.2024.11.010

How many times has this paper been cited?

79 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Journal of Controlled Release: sign in and open the full text from this page.

Who wrote this paper?

Burcu Binici, Zahra Rattray, Assaf Zinger, Yvonne Perrie.

What is the DOI of this paper?

10.1016/j.jconrel.2024.11.010, permanently at https://doi.org/10.1016/j.jconrel.2024.11.010. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.